과제정보
This work was supported by a 2-year research grant from Pusan National University.
참고문헌
- Fazeli B, Poredos P, Patel M, et al. Milestones in thromboangiitis obliterans: a position paper of the VAS-European independent foundation in angiology/vascular medicine. Int Angiol 2021;40:395-408. https://doi.org/10.23736/S0392-9590.21.04712-X
- Buerger L. Thrombo-angitis obliterans; a study of the vascular lesions leading to presenile spontaneous gangrene. Am J Med 1952;13:526-32. https://doi.org/10.1016/0002-9343(52)90015-6
- Mills JL, Porter JM. Buerger's disease (thromboangiitis obliterans). Ann Vasc Surg 1991;5:570-2. https://doi.org/10.1007/BF02015288
- Wysokinski WE, Kwiatkowska W, Sapian-Raczkowska B, Czarnacki M, Doskocz R, Kowal-Gierczak B. Sustained classic clinical spectrum of thromboangiitis obliterans (Buerger's disease). Angiology 2000;51:141-50. https://doi.org/10.1177/000331970005100207
- Olin JW. Thromboangiitis obliterans (Buerger's disease). N Engl J Med 2000;343:864-9. https://doi.org/10.1056/NEJM200009213431207
- Mehra NK, Jaini R. Immunogenetics of peripheral arteriopathies. Clin Hemorheol Microcirc 2000;23:225-32.
- Silbert S. Etiology of thromboangiitis obliterans. JAMA 1945;129:5-9. https://doi.org/0.1001/jama.1945.02860350007002 1001/jama.1945.02860350007002
- Carr ME Jr, Hackney MH, Hines SJ, Heddinger SP, Carr SL, Martin EJ. Enhanced platelet force development despite drug-induced inhibition of platelet aggregation in patients with thromboangiitis obliterans: two case reports. Vasc Endovascular Surg 2002;36:473-80. https://doi.org/10.1177/153857440203600610
- Iwai T, Inoue Y, Umeda M, et al. Oral bacteria in the occluded arteries of patients with Buerger disease. J Vasc Surg 2005;42:107-15. https://doi.org/10.1016/j.jvs.2005.03.016
- Iwai T, Sato, Kume H, et al. Clinical study of phlebitis migrans and incompetence of the leg's superficial vein in Buerger disease. Ann Vasc Dis 2012;5:45-51. https://doi.org/10.3400/avd.oa.11.00044
- Czarnacki M, Gacka M, Adamiec R. A role of endothelin 1 in the pathogenesis of thromboangiitis obliterans (initital news). Przegl Lek 2004;61:1346-50.
- Shionoya S. Diagnostic criteria of Buerger's disease. Int J Cardiol 1998; 66 Suppl 1:S243-5. https://doi.org/10.1016/s0167-5273(98)00175-2
- Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997;26:517-38. https://doi.org/10.1016/s0741-5214(97)70045-4
- Park JS, Kim GE, Min SK, et al. Buerger's disease in Korea. J Korean Soc Vasc Surg 2005;21:105-12.
- Lie JT. The rise and fall and resurgence of thromboangiitis obliterans (Buerger's disease). Acta Pathol Jpn 1989;39:153-8. https://doi.org/10.1111/j.1440-1827.1989.tb01494.x
- Choi B, Jang SY, Kim SK, Kim N, Kim K, Kim DK. The incidence, prevalence, and survival rate of thromboangiitis obliterans in Korea: a retrospective population-based study. Cardiovasc Diagn Ther 2020;10:1238-44. https://doi.org/10.21037/cdt-20-582
- Hirai M, Shinonoya S. Intermittent claudication in the foot and Buerger's disease. Br J Surg 1978;65:210-3. https://doi.org/10.1002/bjs.1800650320
- Mills JL Sr. Buerger's disease in the 21st century: diagnosis, clinical features, and therapy. Semin Vasc Surg 2003;16:179-89. https://doi.org/10.1016/s0895-7967(03)00023-1
- Roth GM, Shick RM. Effect of smoking on the cardiovascular system of man. Circulation 1958;17:443-59. https://doi.org/10.1161/01.cir.17.3.443
- Hooten WM, Bruns HK, Hays JT. Inpatient treatment of severe nicotine dependence in a patient with thromboangiitis obliterans (Buerger's disease). Mayo Clin Proc 1998;73:529-32. https://doi.org/10.4065/73.6.529
- Fazeli B, Dadgar Moghadam M, Niroumand S. How to treat a patient with thromboangiitis obliterans: a systematic review. Ann Vasc Surg 2018;49:219-28. https://doi.org/10.1016/j.avsg.2017.10.022
- Dsouza RJ, Premkumar P, Samuel V, Kota A, Agarwal S. Patterns of arterial involvement and feasibility of revascularization in thromboangiitis obliterans: a tertiary care centre experience. ANZ J Surg 2020;90:2506-9. https://doi.org/10.1111/ans.16417
- Le Joncour A, Soudet S, Dupont A, et al. Long-term outcome and prognostic factors of complications in thromboangiitis obliterans (Buerger's disease): a multicenter study of 224 patients. J Am Heart Assoc 2018;7:e010677. https://doi.org/10.1161/JAHA.118.010677